San Diego, CA, United States of America

Shawn Branum

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Shawn Branum in Neurological Treatments

Introduction

Shawn Branum is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurological and psychiatric disorders. With a total of four patents to his name, Branum's work is paving the way for new therapeutic options.

Latest Patents

Branum's latest patents include innovative compounds that act as inhibitors of the vesicular monoamine transporter 2 (VMAT2). These compounds, detailed in his patent titled "VMAT2 inhibitor compounds and compositions thereof," are designed to provide therapeutic benefits for individuals suffering from various neurological and psychiatric diseases. Additionally, he has developed synthetic methods for the preparation of complex compounds, such as (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate), showcasing his expertise in medicinal chemistry.

Career Highlights

Branum is currently employed at Neurocrine Biosciences, Inc., a company known for its focus on neurological and endocrine diseases. His role at Neurocrine allows him to apply his innovative ideas in a collaborative environment, contributing to the advancement of medical science.

Collaborations

Throughout his career, Branum has worked alongside notable colleagues such as Kevin McGee and Bin-Feng Li. These collaborations have fostered a dynamic exchange of ideas and expertise, enhancing the quality and impact of their research.

Conclusion

Shawn Branum's contributions to the field of pharmaceuticals, particularly in the development of VMAT2 inhibitors, highlight his role as a key innovator in treating neurological disorders. His work continues to inspire advancements in medical treatments and offers hope for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…